BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Zafrakas M, Papasozomenou P, Emmanouilides C. Sorafenib in breast cancer treatment: A systematic review and overview of clinical trials. World J Clin Oncol 2016; 7(4): 331-336 [PMID: 27579253 DOI: 10.5306/wjco.v7.i4.331]
URL: https://www.wjgnet.com/2218-4333/full/v7/i4/331.htm
Number Citing Articles
1
Sharath Mohan Bhat, Palla Ranga Prasad, Manjunath B. Joshi. Epigenetic Regulation of Cancer - Part AInternational Review of Cell and Molecular Biology 2023; 380: 63 doi: 10.1016/bs.ircmb.2023.04.002
2
Shang Liu, Ying Liu, Qing Chang, Christian Celia, Xiaoyong Deng, Yijun Xie. pH-Responsive Sorafenib/Iron-Co-Loaded Mesoporous Polydopamine Nanoparticles for Synergistic Ferroptosis and Photothermal TherapyBiomacromolecules 2024; 25(1): 522 doi: 10.1021/acs.biomac.3c01173
3
Zhuo-Yue Li, Yi-Fan Yin, Yang Guo, Hui Li, Mei-Qi Xu, Man Liu, Jing-Ru Wang, Zhen-Han Feng, Xiao-Chuan Duan, Shuang Zhang, Shuai-Qiang Zhang, Guang-Xue Wang, Ai Liao, Shu-Min Wang, Xuan Zhang. <p>Enhancing Anti-Tumor Activity of Sorafenib Mesoporous Silica Nanomatrix in Metastatic Breast Tumor and Hepatocellular Carcinoma via the Co-Administration with Flufenamic Acid</p>International Journal of Nanomedicine 2020; : 1809 doi: 10.2147/IJN.S240436
4
Lavanya Ponnusamy, Sathan Raj Natarajan, Karthik Thangaraj, Ravi Manoharan. Therapeutic aspects of AMPK in breast cancer: Progress, challenges, and future directionsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(1): 188379 doi: 10.1016/j.bbcan.2020.188379
5
Shi Huang, Yan Chen, Lingyu Pan, Changyi Fei, Ni Wang, Furui Chu, Daiyin Peng, Xianchun Duan, Yongzhong Wang. Exploration of the Potential Mechanism of Tao Hong Si Wu Decoction for the Treatment of Breast Cancer Based on Network Pharmacology and In Vitro Experimental VerificationFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.731522
6
Qi Wang, Nan Cheng, Wei Wang, Yongping Bao. Synergistic Action of Benzyl Isothiocyanate and Sorafenib in a Nanoparticle Delivery System for Enhanced Triple-Negative Breast Cancer TreatmentCancers 2024; 16(9): 1695 doi: 10.3390/cancers16091695
7
Seraphina Choi, Isabella Dreyfuss, Crystal Seldon Taswell, Jonathan Cyriac, Michael Butkus, Cristiane Takita. Proton Beam Therapy for Breast Cancer Critical Reviews™ in Oncogenesis 2024; 29(3): 67 doi: 10.1615/CritRevOncog.2023050319
8
Zahra Sadat Hashemi, Mahlegha Ghavami, Seyed Hossein Kiaie, Fateme Mohammadi, Mahdieh Shokrollahi Barough, Saeed Khalili, Zahra Hosseini-Farjam, Majid Mossahebi-Mohammadi, Alireza Sheidary, Ardeshir Ghavamzadeh, Ramin Sarrami Forooshani. Novel Delivery of Sorafenib by Natural Killer Cell-Derived Exosomes-Enhanced Apoptosis in Triple-Negative Breast CancerNanomedicine 2023; 18(5): 437 doi: 10.2217/nnm-2022-0237
9
Alfeu Zanotto-Filho, Subapriya Rajamanickam, Eva Loranc, V. Pragathi Masamsetti, Aparna Gorthi, July Carolina Romero, Sonal Tonapi, Rosangela Mayer Gonçalves, Robert L. Reddick, Raymond Benavides, John Kuhn, Yidong Chen, Alexander J.R. Bishop. Sorafenib improves alkylating therapy by blocking induced inflammation, invasion and angiogenesis in breast cancer cellsCancer Letters 2018; 425: 101 doi: 10.1016/j.canlet.2018.03.037
10
Jian Li, Kathrin Halfter, Mengying Zhang, Christian Saad, Kai Xu, Bernhard Bauer, Yijiang Huang, Lei Shi, Ulrich R. Mansmann. Computational analysis of receptor tyrosine kinase inhibitors and cancer metabolism: implications for treatment and discovery of potential therapeutic signaturesBMC Cancer 2019; 19(1) doi: 10.1186/s12885-019-5804-0
11
Yujie Shi, Zongmin Zhao, Kevin Peng, Yongsheng Gao, Debra Wu, Jayoung Kim, Samir Mitragotri. Enhancement of Anticancer Efficacy and Tumor Penetration of Sorafenib by Ionic LiquidsAdvanced Healthcare Materials 2021; 10(2) doi: 10.1002/adhm.202001455
12
Debasis Das, Jian Hong. Recent Progress and Development of Small Molecule Kinase Inhibitors for the Treatment of Breast CancerCurrent Enzyme Inhibition 2020; 16(1): 4 doi: 10.2174/1573408016666200228112728
13
Alanoud Altalal, Aliyah Almomen, Musaed Alkholief, Ziyad Binkhathlan, Nourah Z. Alzoman, Aws Alshamsan. Development and validation of a UPLC-MS/MS method for simultaneous detection of doxorubicin and sorafenib in plasma: Application to pharmacokinetic studies in ratsSaudi Pharmaceutical Journal 2023; 31(7): 1317 doi: 10.1016/j.jsps.2023.05.025
14
Rola El Sayed, Lara El Jamal, Sarah El Iskandarani, Jeries Kort, Mahmoud Abdel Salam, Hazem Assi. Endocrine and Targeted Therapy for Hormone-Receptor-Positive, HER2-Negative Advanced Breast Cancer: Insights to Sequencing Treatment and Overcoming Resistance Based on Clinical TrialsFrontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00510
15
Giuseppe Bronte, Daniele Andreis, Sara Bravaccini, Roberta Maltoni, Lorenzo Cecconetto, Alessio Schirone, Alberto Farolfi, Anna Fedeli, Patrizia Serra, Caterina Donati, Dino Amadori, Andrea Rocca. Sorafenib for the treatment of breast cancerExpert Opinion on Pharmacotherapy 2017; 18(6): 621 doi: 10.1080/14656566.2017.1309024
16
Bruna R. Silva, Rita Rebelo, Juliana M. Rodrigues, Cristina P. R. Xavier, M. Helena Vasconcelos, Maria-João R. P. Queiroz. Synthesis of Novel Methyl 3-(hetero)arylthieno[3,2-b]pyridine-2-carboxylates and Antitumor Activity Evaluation: Studies In Vitro and In Ovo Grafts of Chick Chorioallantoic Membrane (CAM) with a Triple Negative Breast Cancer Cell LineMolecules 2021; 26(6): 1594 doi: 10.3390/molecules26061594
17
Hua-Li Wang, Xue Ma, Xin-Yuan Guan, Chen Song, Guo-Bo Li, Ya-Mei Yu, Ling-Ling Yang. Potential synthetic lethality for breast cancer: A selective sirtuin 2 inhibitor combined with a multiple kinase inhibitor sorafenibPharmacological Research 2022; 177: 106050 doi: 10.1016/j.phrs.2021.106050
18
Fiona L. Cousins, Dorien F. O, Caroline E. Gargett. Endometrial stem/progenitor cells and their role in the pathogenesis of endometriosisBest Practice & Research Clinical Obstetrics & Gynaecology 2018; 50: 27 doi: 10.1016/j.bpobgyn.2018.01.011
19
Leilei Gou, Grace Gar-Lee Yue, Pema Tenzin Puno, Clara Bik-San Lau. A review on the relationship of mast cells and macrophages in breast cancer — Can herbs or natural products facilitate their anti-tumor effects?Pharmacological Research 2021; 164: 105321 doi: 10.1016/j.phrs.2020.105321
20
Hebatullah M. Abou El-Fadl, Naglaa M. Hagag, Reham A. El-Shafei, Mohamed H. Khayri, Gamalat El-Gedawy, Ahmed I. Abd El Maksoud, Doaa D. Mohamed, Dalia D. Mohamed, Ibrahim El Halfawy, Ahmed I. Khoder, Khaled A. Elawdan, Mohamed F. Elshal, Ahmed Salah, Hany Khalil. Effective Targeting of Raf-1 and Its Associated Autophagy by Novel Extracted Peptide for Treating Breast Cancer CellsFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.682596
21
Fatemeh Khojasteh Poor, Mona Keivan, Mohammad Ramazii, Farhoodeh Ghaedrahmati, Amir Anbiyaiee, Samira Panahandeh, Seyed Esmaeil Khoshnam, Maryam Farzaneh. Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancerBreast Disease 2021; 40(2): 51 doi: 10.3233/BD-201063
22
Jin Shang, Shanling Xu, Jiaxing Zhang, Xuting Ran, Lang Bai, Hong Tang. Efficacy of sorafenib in patients with hepatocellular carcinoma after resection: a meta-analysisOncotarget 2017; 8(65): 109723 doi: 10.18632/oncotarget.21299
23
Jing Zhang, Kun Yu, Xuedong Han, Linlin Zhen, Minmin Liu, Xiwen Zhang, Yi Ren, Jianhua Shi. Paeoniflorin influences breast cancer cell proliferation and invasion via inhibition of the Notch‑1 signaling pathwayMolecular Medicine Reports 2017;  doi: 10.3892/mmr.2017.8002
24
Nishtha Chaurawal, Charu Misra, Harshita Abul Barkat, Reena Jatyan, Deepak Chitkara, Md. Abul Barkat, Teenu Sharma, Bhupinder Singh, Kaisar Raza. Oral sorafenib-loaded microemulsion for breast cancer: evidences from the in-vitro evaluations and pharmacokinetic studiesScientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17333-6
25
Multiwalled carbon nanotubes co-delivering sorafenib and epidermal growth factor receptor siRNA enhanced tumor-suppressing effect on liver cancerAging 2021; 13(2): 1872 doi: 10.18632/aging.103905
26
Ahmed A. Abdelgalil, Hamad M. Alkahtani, Fahad I. Al-Jenoobi. Profiles of Drug Substances, Excipients, and Related MethodologyProfiles of Drug Substances, Excipients and Related Methodology 2019; 44: 239 doi: 10.1016/bs.podrm.2018.11.003
27
Agnieszka Karbownik, Katarzyna Sobańska, Tomasz Grabowski, Joanna Stanisławiak-Rudowicz, Anna Wolc, Edmund Grześkowiak, Edyta Szałek. In vivo assessment of the drug interaction between sorafenib and paracetamol in ratsCancer Chemotherapy and Pharmacology 2020; 85(6): 1039 doi: 10.1007/s00280-020-04075-3
28
Taobo Hu, Wei Hou, Enhua Xiao, Mengping Long. Mechanism and effect of stress granule formation in cancer and its potential roles in breast cancer therapyGenes & Diseases 2022; 9(3): 659 doi: 10.1016/j.gendis.2021.02.005
29
Doaa S. R. Khafaga, Ahmed M. El-Khawaga, Rehab Abd Elfattah Mohammed, Heba K. Abdelhakim. Green synthesis of nano-based drug delivery systems developed for hepatocellular carcinoma treatment: a reviewMolecular Biology Reports 2023; 50(12): 10351 doi: 10.1007/s11033-023-08823-5
30
Jia Fu, Wenpan Li, Xiu Xin, Dawei Chen, Haiyang Hu. Transferrin-Modified Nanoliposome Codelivery Strategies for Enhancing the Cancer TherapyJournal of Pharmaceutical Sciences 2020; 109(8): 2426 doi: 10.1016/j.xphs.2019.11.013
31
Yogita Chhichholiya, Prabhat Suman, Sandeep Singh, Anjana Munshi. The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategiesMedical Oncology 2021; 38(8) doi: 10.1007/s12032-021-01547-1
32
Francesca Laneri, Adriana C. E. Graziano, Mimimorena Seggio, Aurore Fraix, Milo Malanga, Szabolcs Béni, Giuseppe Longobardi, Claudia Conte, Fabiana Quaglia, Salvatore Sortino. Enhancing the Anticancer Activity of Sorafenib through Its Combination with a Nitric Oxide Photodelivering β-Cyclodextrin PolymerMolecules 2022; 27(6): 1918 doi: 10.3390/molecules27061918
33
Bui Thanh Tung, Nguyen Nhu Son, Nguyen Bao Kim, Do Thi Hong Khanh, Phan Hong Minh. In silico screening of alkaloids as potential inhibitors of HER2 protein for breast cancer treatmentVietnam Journal of Chemistry 2023; 61(3): 308 doi: 10.1002/vjch.202200135
34
Ahmed Elwakeel, Hadeer Soudan, Ahmad Eldoksh, Manal Shalaby, Maha Eldemellawy, Doaa Ghareeb, Myriam Abouseif, Amira Fayad, Mostafa Hassan, Hesham Saeed. Implementation of the Chou-Talalay method for studying the in vitro pharmacodynamic interactions of binary and ternary drug combinations on MDA-MB-231 triple negative breast cancer cellsSynergy 2019; 8: 100047 doi: 10.1016/j.synres.2019.100047
35
Nidhi Gupta, Hitesh Kumar, Sumeet Gupta, Basavarajaiah S. M., Kamal Saini. A Concise Review on Natural Products and Their Derivatives for Breast Cancer TreatmentChemistry & Biodiversity 2023; 20(8) doi: 10.1002/cbdv.202300688
36
Sreeja Dattachoudhury, Renu Sharma, Atul Kumar, Bithiah Grace Jaganathan. Sorafenib Inhibits Proliferation, Migration and Invasion of Breast Cancer CellsOncology 2020; 98(7): 478 doi: 10.1159/000505521
37
Joanna Wawszczyk, Radosław Wolan, Sławomir Smolik, Małgorzata Kapral. In vitro and in silico study on the effect of carvedilol and sorafenib alone and in combination on the growth and inflammatory response of melanoma cellsSaudi Pharmaceutical Journal 2023; 31(7): 1306 doi: 10.1016/j.jsps.2023.05.020
38
Zeynep Oruç, Muhammet Ali Kaplan, Çağatay Arslan. An update on the currently available and future chemotherapy for treating bone metastases in breast cancer patientsExpert Opinion on Pharmacotherapy 2018; 19(12): 1305 doi: 10.1080/14656566.2018.1504922
39
Teresa Faranda, Ilaria Grossi, Michele Manganelli, Eleonora Marchina, Gianluca Baiocchi, Nazario Portolani, Marialuisa Crosatti, Giuseppina De Petro, Alessandro Salvi. Differential expression profiling of long non-coding RNA GAS5 and miR-126-3p in human cancer cells in response to sorafenibScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45604-2